Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Universal Systemic Core of 3D Immunogenetic Profiling across Multiple Oncological Indications
Mahkota Medical Centre
PRINCIPAL INVESTIGATOR
Dr Hayani Abd Wahid
CONTACT
SC: Siti Zawiyah Ismail/ Justin Liu
CRC: 010-2408344/06-2852739
Marker Assisted Selective ThErapy in Rare cancers: Knowledge database Establishing registrY Protocol
Kuala Lumpur Hospital (HKL)
PRINCIPAL INVESTIGATOR
Najihah Binti Abu Bakar
CONTACT
Siti Zubaidah
National Cancer Institute (IKN)
PRINCIPAL INVESTIGATOR
Suhana Binti Yusak
CONTACT
Hidayati
Pulau Pinang Hospital
PRINCIPAL INVESTIGATOR
Soo Hoo Hwoei Fen
CONTACT
Dhinesweri
Sarawak General Hospital
PRINCIPAL INVESTIGATOR
Voon Pei Jye
CONTACT
Dafne Diana, Nur Haziqah
Sultan Ismail Hospital, Johor Bahru
PRINCIPAL INVESTIGATOR
Rangasamy A/L Ramachandran
CONTACT
Sri Ratha